[Effect of 16, 16-dimethylprostaglandin E2 on the electrolyte barrier of the stomach in patients with peptic ulcer].
D015064:16,16-Dimethylprostaglandin E2 / Q000627:therapeutic use*; D000328:Adult; D004573:Electrolytes / Q000378:metabolism*; D005753:Gastric Mucosa / Q000378:metabolism*; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000188:drug therapy* / Q000378:metabolism; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*
D004573:Electrolytes; D011459:Prostaglandins E, Synthetic; D015064:16,16-Dimethylprostaglandin E2
Wpływ 16, 16-dwumetyloprostaglandyny E2 na bariere elektrolitowa zoładka u ludzi z choroba wrzodowa zoładka i dwunastnicy.